Third of breast cancer patients treated unnecessarily, study says

The examine raises the uncomfortable chance that some ladies who consider their lives have been saved by mammograms have been really harmed by most cancers screenings that led to surgical procedure, radiation and even chemotherapy that they did not want, stated Dr. Otis Brawley, chief medical officer of the American Most cancers Society, who wrote an accompanying editorial however was not concerned within the examine.

Researchers more and more acknowledge that not all breast cancers pose the identical danger, even when they give the impression of being the identical underneath a microscope, Brawley stated. Whereas some early tumors flip into lethal monsters, others cease rising and even shrink. However assuming that every one small breast lesions have the potential to show lethal is akin to "racial profiling," Brawley wrote in his editorial.

"By treating all of the cancers that we see, we're clearly saving some lives," Brawley stated in an interview. "However we're additionally 'curing' some ladies who do not should be cured."

Though consultants corresponding to Brawley have lengthy mentioned the dangers posed by "overdiagnosis," comparatively few ladies who endure most cancers screenings are even conscious of the controversy.

The American Faculty of Radiology, which strongly helps breast most cancers screenings, acknowledges that mammograms lead some ladies to be handled unnecessarily, however stated the issue is far much less frequent than the brand new examine suggests. One other examine from Denmark -- whose nationwide well being program retains detailed data -- estimated the overdiagnosis charges at solely 2.three p.c.

"The quantity of overdiagnosis actually is small," stated Dr. Debra Monticciolo, chair of the American Faculty of Radiology's Fee on Breast Imaging. "Articles like this aren't very useful," she stated, as a result of they go away ladies confused about how one can be screened for breast most cancers.

But treating ladies for most cancers unnecessarily can endanger their well being, stated Fran Visco, president of the Nationwide Breast Most cancers Coalition, an advocacy group. Radiation can harm the center and even trigger new cancers. Visco notes that breast most cancers activist Carolina Hinestrosa, a vp on the coalition, died at age 50 from soft-tissue sarcoma, a tumor attributable to radiation used to deal with an early breast most cancers.

Girls ought to perceive these dangers, Visco stated. As a substitute, ladies usually hear solely about mammograms' advantages.

"Girls have been inundated with the early detection message for many years," Visco stated.

The dangers of overdiagnosis and false positives, which might lead ladies with benign growths to endure biopsies and different follow-up assessments, have precipitated some consultants to reevaluate breast most cancers screenings. Though mammograms do not discover all tumors, they scale back the chance of dying from breast most cancers by 25 p.c to 31 p.c for ladies ages 40 to 69, in response to the Company for Healthcare Analysis and High quality, a part of the Division of Well being and Human Providers.

Medical teams now supply differing recommendation on mammograms:

• The American Faculty of Radiology takes essentially the most aggressive stance, recommending annual mammograms starting at age 40. Tumors must be discovered once they're "smaller and simpler to deal with," Monticciolo stated.
• The U.S. Preventive Providers Process Pressure, an unbiased knowledgeable panel that advises the federal authorities on well being, provoked a firestorm of criticism in 2009 when it bucked that recommendation, recommending that ladies get mammograms each different yr starting at age 50. The group famous that breast most cancers danger rises with age, so mammograms usually tend to uncover most cancers -- versus benign growths -- after age 50.
• The American Most cancers Society additionally scaled again its screening recommendation in 2015, recommending ladies get annual mammograms from 45 to 54, adopted by screenings each different yr after that.

Within the new examine, Danish researchers estimated the speed of overdiagnosis by evaluating the variety of early-stage and superior breast tumors earlier than and after the nation began providing mammograms. If screenings work as supposed, the variety of small, curable breast tumors ought to enhance, whereas decreasing the variety of massive cancers by about the identical quantity.

Though mammograms in Denmark detected much more breast cancers, these have been principally small, early-stage tumors, stated examine coauthor Dr. Karsten Jorgensen, a researcher on the Nordic Cochrane Middle in Copenhagen, Denmark. The variety of superior cancers didn't fall.

The controversy about overdiagnosis illustrates the bounds of medical know-how, Brawley stated.

Though researchers can estimate the statistical charge of overdiagnosis, docs treating precise sufferers cannot definitively inform which breast tumors want remedy and which could be safely ignored, Brawley stated. So docs are inclined to err on the aspect of warning and deal with all breast cancers with surgical procedure and, in lots of circumstances, radiation and chemotherapy.

An estimated 253,000 new circumstances of breast most cancers can be identified within the U.S. ladies this yr, with practically 41,000 deaths, in response to the American Most cancers Society.

A further 63,000 ladies can be identified with ductal carcinoma in situ, often known as DCIS, which has some, however not all, of the everyday traits of most cancers. Though DCIS cells have modified to look malignant underneath the microscope, they have not invaded surrounding tissue.

The American Most cancers Society defines DCIS because the earliest stage of breast most cancers, and ladies with the situation sometimes endure the identical remedy given to ladies with early invasive cancers. Though DCIS is not life-threatening, docs advocate treating it to forestall it from turning into invasive.

Different consultants be aware that DCIS carries such low danger that it must be thought-about merely a danger issue for most cancers. Researchers are conducting research to measure whether or not it is protected to reduce remedy of DCIS.